about
Vitamin D plasma levels and in-hospital and 1-year outcomes in acute coronary syndromes: a prospective studyAcute Kidney Injury Definition and In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.Vitamin D and acute myocardial infarction.B-type natriuretic peptide levels in patients with pericardial effusion undergoing pericardiocentesis.Brain natriuretic peptide in acute myocardial infarction: a marker of cardio-renal interaction.Myocardial Infarct Size in Patients on Long-Term Statin Therapy Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.Diagnostic and Prognostic Utility of Circulating Cytochrome c in Acute Myocardial Infarction.B-type natriuretic peptide and risk of acute kidney injury in patients hospitalized with acute coronary syndromes*.Continuous ultrafiltration for congestive heart failure: the CUORE trial.Extracorporeal ultrafiltration for acute heart failure: patient selection and perspectives.Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Acute Myocardial Infarction: A Prospective Study.Prognostic significance of serum creatinine and its change patterns in patients with acute coronary syndromesIncidence and Relevance of Acute Kidney Injury in Patients Hospitalized With Acute Coronary SyndromesContrast-induced nephropathySerum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction[Mild therapeutic hypothermia for the treatment of cardiac arrest and acute myocardial infarction]Renal replacement therapy in patients with acute myocardial infarction: Rate of use, clinical predictors and relationship with in-hospital mortalityContinuous ultrafiltration for congestive heart failure: the CUORE trial
P50
Q36151577-F841A387-5D3F-4F01-B74D-AC46A252CA0BQ37240720-1E774671-859E-460B-9BC1-D9091C9BE437Q37597742-0E5E49C9-1F89-4990-979E-A806A373FC52Q38884063-45725376-82C6-475E-B1EC-5F028CE667D6Q38918910-0D4D4121-2A1C-411A-B21C-561F2D69C05DQ38939236-B836F62F-B7BA-4C06-9560-AF8316003B33Q40501284-07CCE2D1-8F57-428E-A56C-0C5B9CE316D6Q43610719-004B3D40-72EC-4115-8FFF-1695FE7F4549Q44870202-94EF30B5-9AB7-43DD-9B32-9957BA0F9580Q47112008-46B5ED73-AFB3-4A8E-947D-AC7D334982A8Q48139590-40F8D6A2-7657-42B8-B72D-906B3C89360FQ61387386-1C90C6AF-B211-4A45-B2AD-BF964BE8FE89Q61387394-8B203133-609B-4E06-BC28-657C498E3448Q61387403-95C2D7D3-AAD6-473A-8DD0-729B8D37050CQ83970061-DF162D2A-00B6-43A0-AB8A-DA24DA0D859EQ87435878-2E6988E6-7389-4936-A57A-69CF1953A37EQ89430419-01445AEF-E2FC-43E9-84CB-C4E79F4ED078Q95467920-C23F176F-44F6-42A2-9B23-5CE75C2FA24C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Valentina Milazzo
@ast
Valentina Milazzo
@en
Valentina Milazzo
@es
Valentina Milazzo
@nl
type
label
Valentina Milazzo
@ast
Valentina Milazzo
@en
Valentina Milazzo
@es
Valentina Milazzo
@nl
prefLabel
Valentina Milazzo
@ast
Valentina Milazzo
@en
Valentina Milazzo
@es
Valentina Milazzo
@nl
P106
P31
P496
0000-0002-4864-0387